CBD News
Nootropics Company TruBrain is Entering the CBD-Infused Smart Drug Product World
- TruBrain Hopes To Make $1 Million in New Capital With Their Crowdfunding Campaign.
- Investors can receive free products from the brand for contributing to the brand.
TruBrain is bringing new products to the CBD market, launching a remedy that offers both hemp extract and a smart drug formula, the latter of which is still patent-pending. However, instead of funding this project on their own, the company initiated a crowdfunding campaign. As they invited everyday investors to take an ownership stake in the product, they set a goal to raise $1 million in new capital.
Previously, with the help of venture capital firms and angel investors, TruBrain raised $1.6 million. Earlier this year, the company raised $12 million in lifetime sales for their cognition-enhancing formulas. Founder and CEO Chris Thompson of TruBrain recently spoke with Benzinga,
“Our mission is to help people do their best thinking – that’s why we are excited about CBD. Our preliminary research has shown that CBD has a unique ability to block stress and anxiety, paving the way for TruBrain nootropics to deliver the most dramatic outcomes of mental endurance and break through procrastination.”
TruBrain presently has a broad range of nootropic remedies, offering a plethora of information on the science that backs up their products. Divided into Brain Food and Ketones, consumers can purchase drinks and snacks to support the health of their brain. As an incentive to get more investments, the company offers a promotion on their website to receive $299 in free product for their contributions.
Consumers can learn more about TruBrain by visiting https://www.trubrain.com/. The company can be reached by emailing team@trubrain.com.